{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:26:28Z","timestamp":1764570388047},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2984,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/jto.0b013e318153f8db","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T10:41:25Z","timestamp":1209897685000},"page":"953-956","source":"Crossref","is-referenced-by-count":1,"title":["Irinotecan-Cisplatin Therapy for Patients with Extensive-Stage Small Cell Lung Cancer: Use Patterns among American Medical Oncologists 2000\u20132006"],"prefix":"10.1016","volume":"2","author":[{"given":"Mark R.","family":"Green","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Dowlati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalitha","family":"Yellamraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Willey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Leff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e318153f8db_bib1","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM199211123272006","article-title":"Chemotherapy of lung cancer","volume":"327","author":"Ihde","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e318153f8db_bib2","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.1996.14.2.658","article-title":"Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat","volume":"14","author":"Aisner","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jnci\/93.4.300","article-title":"Etoposide plus cisplatin with or without the combination of 4\u2032-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study","volume":"93","author":"Pujol","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e318153f8db_bib4","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2005.09.071","article-title":"Randomized Phase III Intergroup Trial of Etoposide and Cisplatin With or Without Paclitaxel and Granulocyte Colony-Stimulating Factor in Patients With Extensive-Stage Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 9732","volume":"23","author":"Niell","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib5","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1200\/JCO.2001.19.8.2114","article-title":"Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593\u2013a phase III trial of the Eastern Cooperative Oncology Group","volume":"19","author":"Schiller","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib6","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1200\/JCO.1999.17.8.2300","article-title":"Randomized study of CODE versus alternating CAV\/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group","volume":"17","author":"Murray","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission: Prophylactic Cranial Irradiation Overview Collaborative Group","volume":"341","author":"Auperin","year":"1999","journal-title":"N Engl J Med"},{"issue":"1 Suppl 3","key":"10.1097\/JTO.0b013e318153f8db_bib8","first-page":"21","article-title":"CPT-11: an original spectrum of clinical activity","volume":"23","author":"Rothenberg","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1200\/JCO.1992.10.8.1225","article-title":"CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer","volume":"10","author":"Masuda","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1200\/JCO.1998.16.3.1068","article-title":"Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer","volume":"16","author":"Kudoh","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMoa003034","article-title":"Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer","volume":"346","author":"Noda","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e318153f8db_bib12","first-page":"a1887","article-title":"Randomized phase III study of irinotecan (CPT-11) and cisplatin versus etoposide and cisplatin in extensive-disease small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG9511)","volume":"19","author":"Noda","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib13","first-page":"a2537","article-title":"Interim safety analysis of irinotecan and cisplatin combination chemotherapy for previously untreated extensive small cell lung cancer","volume":"22","author":"Sandler","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib14","doi-asserted-by":"crossref","first-page":"a7004","DOI":"10.1200\/jco.2005.23.16_suppl.lba7004","article-title":"Randomized, phase III trial comparing irinotecan\/cisplatin (IP) with etoposide\/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC)","volume":"23","author":"Hanna","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib15","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2005.04.8595","article-title":"Randomized phase III trial comparing irinotecan\/cisplatin with etoposide\/cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer","volume":"24","author":"Hanna","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1634\/theoncologist.11-1-31","article-title":"How do U.S. medical oncologists learn and apply new clinical trials information from press releases in non-medical media? A case study based on ECOG 4599","volume":"11","author":"Dornbusch","year":"2006","journal-title":"Oncologist"},{"key":"10.1097\/JTO.0b013e318153f8db_bib17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer: Irinotecan study group","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e318153f8db_bib18","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e318153f8db_bib19","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1200\/JCO.2006.06.1317","article-title":"Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: A North American Intergroup study","volume":"24","author":"Goldberg","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318153f8db_bib20","series-title":"Getting Research Findings into Practice","first-page":"27","article-title":"Closing the gap between research and practice","author":"Bero","year":"1998"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415308960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415308960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T04:53:04Z","timestamp":1546059184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415308960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1556086415308960"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e318153f8db","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}